3C-P
3,5-dimethoxy-4-propoxyamphetamine
1Provenance card
the boundary, as counts
Sources
2114 with DOI
6 strong · 9 moderate · 6 weak
Compilations
12026-05-11T04:27:15.324Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
34last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:29:47.072Z
notice · info card · emergency
Searches
210 with no results
queries and counts on the build
Claims checked
5235 supported
35 supported · 17 not
Correspondence
0received
consent field ships in Phase 4
Edges
197
derivations recorded for this entity
Complete over 21 sources, 1 compilation, and 34 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/3c-p/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-07srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
- 2026-09-07src2C or Not 2C: Phenethylamine Designer Drug Review
- 2026-09-07srcPharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants
- 2026-09-07srcRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
- 2026-09-07srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- 2026-09-07srcReceptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
- 2026-09-07srcComparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
- 2026-09-07srcAcute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
- 2026-09-07srcSafety pharmacology of acute mescaline administration in healthy participants
- 2026-09-07srcComparison of the behavioral effects of mescaline analogs using the head twitch response in mice
- 2026-09-07srcPeakAL: Protons I Have Known and Loved — NMR spectra of psychedelic phenylethanamines including TMA-2
- 2026-09-07srcReceptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
- 2026-09-07srcThe Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review
- 2026-09-07srcMultimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.
- 2026-09-07srcHallucinogens
- 2026-09-07srcDihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives
- 2026-09-07src3C-P - Erowid Experience Report: Slow Burn
- 2026-09-07src3C-P - Erowid Experience Report: Smooth, Fun, Therapeutic - A Nice Surprise
- 2026-09-07srcErowid 3C-P Vault: Brief 3C-P Information
- 2026-09-07srcPiHKAL Entry #140: Proscaline
- 2026-09-07src3C-P - Erowid Experience Report: Euphoric Stimmy Rollercoaster
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal32 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-11revisionRevision 1
- 2026-05-11genGeneration — pipeline-v5 · with 1 morepipeline-v5
- 2026-05-11rungeneration run
The same entries, as forms: six forms.